摘要
Objective To appraise the sensitivity of hFABP for myocardial ischemia in patients undergoing off-pump coronary artery bypass grafting among cardiac markers. Methods Thirty-eight consecutive patients undergoing OPCABG were included in a randomized study using standardized operative procedures and myocardial protection. Serial blood samples were taken preoperatively, during anastomoses, at the end of operation, 6 h, 18 h and 36 h postoperatively and tested for hFABP、Troponin I (cTnI)、sCD40L、creatine kinase isoenzyme (CK-MB). Results Six cases (16.7%) were found myocardial injury during the OPCABG by ECG or PAP. Their serial serum hFABP,cTnI,sCD40L,CK-MB were higher than those without myocardial injury. The peak serum level of hFABP was higher and occurred earlier than those of cTnI,sCD40L,CK-MB. Conclusion These results suggest that serum hFABP is an early and sensitive biochemical marker for the diagnosis of myocardial injury in patients undergoing OPCABG.
Objective To appraise the sensitivity of hFABP for myocardial ischemia in patients undergoing off-pump coronary artery bypass grafting among cardiac markers. Methods Thirty-eight consecutive patients undergoing OPCABG were included in a randomized study using standardized operative procedures and myocardial protection. Serial blood samples were taken preoperatively, during anastomoses, at the end of operation, 6 h, 18 h and 36 h postoperatively and tested for hFABF,Troponin Ⅰ (cTnⅠ) ,sCD40L,creatine kinase isoenzyme (CK-MB). Results Six cases (16.7%) were found myocardial injury during the OPCABG by ECG or PAP. Their serial serum hFABP,cTnⅠ,sCD40L, CK-MB were higher than those without myocardial injury. The peak serum level of hFABP was higher and occurred earlier than those of cTnⅠ, sCD40L,CK-MB. Conclusion These results suggest that serum hFABP is an early and sensitive biochemical marker for the diagnosis of myocardial injury in patients undergoing OPCABG.
出处
《国际麻醉学与复苏杂志》
CAS
2006年第3期158-160,共3页
International Journal of Anesthesiology and Resuscitation
基金
江苏省医学重点学科徐州医学院附属医院(麻醉学)资助(项目编号WK200203)